Related Experiment Video
Updated: Mar 14, 2026

08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
7.7K
Transcriptome combined with single-cell data to construct a prognostic model for glycosylation-related genes in
Ning Ding1, Jinlong Li1, Songbo Shi1
1Sports Medicine ward, Gansu Provincial Hospital, Lanzhou, 730000, Gansu, China.
Discover Oncology
|March 13, 2026
Summary
Seven glycosylation-related genes (GRGs) were identified as prognostic markers for osteosarcoma (OS). These findings offer a new benchmark for predicting OS prognosis and guiding treatment strategies.
Area of Science:
- Oncology
- Genetics
- Bioinformatics
Background:
- Osteosarcoma (OS) is a primary bone cancer originating from mesenchymal cells.
- Glycosylation plays a crucial role in cancer cell adhesion, metastasis, and transformation.
- Research on glycosylation-related genes (GRGs) in OS remains limited.
Purpose of the Study:
- To identify prognostic glycosylation-related genes (GRGs) in osteosarcoma (OS).
- To develop a prognostic model for OS based on identified GRGs.
- To explore the molecular mechanisms and immune microenvironment associated with OS prognosis.
Main Methods:
- Utilized OS datasets (GSE36001, TARGET-OS, GSE21257) and a scRNA-seq dataset (GSE152048) with 582 GRGs.
- Employed differential expression analysis and Weighted Gene Co-expression Network Analysis (WGCNA) for gene identification.
- Applied univariate Cox regression and LASSO regression for prognostic gene filtering and risk score generation.
Main Results:
- Identified seven GRGs (DCN, RENBP, UAP1, B4GALNT1, CCDC115, TUBA1A, B3GALT4) as prognostic markers for OS.
- Developed a risk model categorizing patients into high- and low-risk groups, with the low-risk group showing improved survival.
- Found activated immune and apoptosis pathways in the high-risk group, correlating with poorer prognosis; identified osteoblastic cells as key cells involved in cell-cell communication.
Conclusions:
- Successfully identified seven prognostic GRGs for osteosarcoma (OS).
- Constructed prognostic models and explored underlying molecular mechanisms.
- These findings provide a valuable benchmark for OS prognosis and treatment strategies.

